PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response

被引:422
|
作者
Zhang, Feng [2 ]
Ma, Jianglin [1 ]
Wu, Jiaxue [2 ]
Ye, Lin [2 ]
Cai, Hong [1 ]
Xia, Bing [1 ]
Yu, Xiaochun [2 ]
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, Canc Inst New Jersey, New Brunswick, NJ 08903 USA
[2] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
FANCONI-ANEMIA; CANCER SUSCEPTIBILITY; S-PHASE; PHOSPHORYLATION; ATM; BACH1; RECOMBINATION; CHECKPOINT; PARTNER; PROTEIN;
D O I
10.1016/j.cub.2009.02.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BRCA1 and BRCA2 are often mutated in familial breast and ovarian cancer. Both tumor suppressors play key roles in the DNA-damage response [1, 2]. However, it remains unclear whether these two tumor suppressor function together in the same DNA-damage response pathway. Here, we show that BRCA1 associates with BRCA2 through PALB2/FANCN, a major binding partner of BRCA2 [3]. The interaction between BRCA1 and BRCA2 is abrogated in PAL132-deficient Fanconi anemia cells and in the cells depleted of PALB2 by small interfering RNA. Moreover, we show that BRCA1 promotes the concentration of PALB2 and BRCA2 at DNA-damage sites and the interaction between BRCA1 and PALB2 is important for the homologous recombination repair. Taken together, our results indicate that BRCA1 is an upstream regulator of BRCA2 in the DNA-damage response, and PALB2 is the linker between BRCA1 BRCA2.
引用
收藏
页码:524 / 529
页数:6
相关论文
共 50 条
  • [31] Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status
    Figueiredo, Jane C.
    Brooks, Jennifer D.
    Conti, David V.
    Poynter, Jenny N.
    Teraoka, Sharon N.
    Malone, Kathleen E.
    Bernstein, Leslie
    Lee, Won D.
    Duggan, David J.
    Siniard, Ashley
    Concannon, Patrick
    Capanu, Marinela
    Lynch, Charles F.
    Olsen, Jorgen H.
    Haile, Robert W.
    Bernstein, Jonine L.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (03) : 819 - 829
  • [32] PARylation of BRCA1 limits DNA break resection through BRCA2 and EXO1
    Lodovichi, Samuele
    Quadri, Roberto
    Sertic, Sarah
    Pellicioli, Achille
    CELL REPORTS, 2023, 42 (02):
  • [33] Screening and Clinical Implications for BRCA1 and BRCA2 Mutation Carriers
    Sharon E. Plon
    Journal of Mammary Gland Biology and Neoplasia, 1998, 3 : 377 - 387
  • [34] Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency
    Bajrami, Ilirjana
    Walker, Callum
    Krastev, Dragomir B.
    Weekes, Daniel
    Song, Feifei
    Wicks, Andrew J.
    Alexander, John
    Haider, Syed
    Brough, Rachel
    Pettitt, Stephen J.
    Tutt, Andrew N. J.
    Lord, Christopher J.
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [35] BRCA1, BRCA2 and breast cancer:: a concise clinical review
    Carter, RF
    CLINICAL AND INVESTIGATIVE MEDICINE, 2001, 24 (03): : 147 - 157
  • [36] BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality
    Khalizieva, Anna
    Moser, Sarah C.
    Bouwman, Peter
    Jonkers, Jos
    GENES & DEVELOPMENT, 2025, 39 (1-2) : 86 - 108
  • [37] Proline variants in the BRCA1 coiled-coil domain disrupt folding and binding to PALB2
    Baker, Chrissy N. S.
    Pajela, Precious Grace C.
    Martin, Davis E.
    Dzyuba, Sergei V.
    Stewart, Mikaela D.
    PROTEIN SCIENCE, 2025, 34 (01)
  • [38] Heterozygous mutations in PALB2 cause DNA replication and damage response defects
    Nikkila, Jenni
    Parplys, Ann Christin
    Pylkas, Katri
    Bose, Muthiah
    Huo, Yanying
    Borgmann, Kerstin
    Rapakko, Katrin
    Nieminen, Pentti
    Xia, Bing
    Pospiech, Helmut
    Winqvist, Robert
    NATURE COMMUNICATIONS, 2013, 4
  • [39] Molecular functions of BRCA1 in the DNA damage response
    Scully, R
    Xie, AY
    Nagaraju, G
    CANCER BIOLOGY & THERAPY, 2004, 3 (06) : 521 - 527
  • [40] Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes
    Pietragalla, Antonella
    Arcieri, Martina
    Marchetti, Claudia
    Scambia, Giovanni
    Fagotti, Anna
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (11) : 1803 - 1810